Sabine Linn

Citado por

	Total	Desde 2020
Citas	20438	8722
Índice h	73	45
Índice i10	225	170

1900

950

475

1425

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202559 59 72 136 201 214 197 150 247 390 517 651 742 890 989 1004 1131 1169 1181 1255 1428 1701 1718 1786 1803 265

Acceso público

Ver todo

116 artículos

10 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Hugo M. HorlingsMD PhD, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsDirección de correo verificada de nki.nl
J Bueno-de-MesquitaAntes / SprinkDirección de correo verificada de sprink.nl
Lodewyk WesselsProfessor of Computational Cancer BiologyDirección de correo verificada de nki.nl
Wilbert ZwartProfessor Functional Genomics in Oncology, Groupleader, The Netherlands Cancer InstituteDirección de correo verificada de nki.nl
W. van HartenNetherlands Cancer Institute; Universiteit Twente, OECI, ex-CEO-Rijnstate, Innovation Fund Denmark.Dirección de correo verificada de hetnet.nl
Matt van de RijnProfessor of Pathology, Stanford UniversityDirección de correo verificada de stanford.edu
Marjanka K SchmidtNetherlands Cancer InstituteDirección de correo verificada de nki.nl
Petra M NederlofNetherlands Cancer Institute NKIDirección de correo verificada de nki.nl
Tesa SeversonNetherlands Cancer InstituteDirección de correo verificada de nki.nl
Torsten NielsenProfessor of Pathology, University of British ColumbiaDirección de correo verificada de mail.ubc.ca
Jos JonkersProfessor at Leiden University and group leader at Netherlands Cancer Institute, Oncode InstituteDirección de correo verificada de nki.nl
Fatima CardosoBreast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, PortugalDirección de correo verificada de fundacaochampalimaud.pt
Rajiv M. Patel, M.D.Cutaneous Pathology WCP Labs Inc.Dirección de correo verificada de wcplab.com
Ben Van CalsterProfessor of Medical Statistics, KU LeuvenDirección de correo verificada de kuleuven.be
Jacques NeefjesHoogleraar cell biologie en immunologie, Leiden UniversiteitDirección de correo verificada de nki.nl
Hein PutterProfessor of Medical Statistics, Leiden University Medical CenterDirección de correo verificada de lumc.nl
Oscar krijgsmanPrinciple Bioinformatician, Neogene TherapeuticsDirección de correo verificada de neogene.com
Paul RoepmanHartwig Medical FoundationDirección de correo verificada de hartwigmedicalfoundation.nl
Tina Hernandez-BoussardAssociate Dean of Research, Professor of Medicine, Stanford UniversityDirección de correo verificada de stanford.edu
Erik H. van BeersSanquin Diagnostic Services B.V.Dirección de correo verificada de sanquin.nl

Seguir

Sabine Linn

Professor of Translational Oncology - Utrecht University; Group leader NKI Amsterdam

Dirección de correo verificada de nki.nl

breast cancer biomarkers endocrine therapy resistance BRCAness


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer K Berns, HM Horlings, BT Hennessy, M Madiredjo, EM Hijmans, K Beelen, ... Cancer cell 12 (4), 395-402, 2007	1936	2007
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ... Nature medicine 25 (6), 920-928, 2019	815	2019
Molecular characterisation of soft tissue tumours: a gene expression study TO Nielsen, RB West, SC Linn, O Alter, MA Knowling, JX O'Connell, S Zhu, ... The Lancet 359 (9314), 1301-1307, 2002	750	2002
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model R Meuwissen, SC Linn, RI Linnoila, J Zevenhoven, WJ Mooi, A Berns Cancer cell 4 (3), 181-189, 2003	684	2003
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study MC van Maaren, L de Munck, GH de Bock, JJ Jobsen, T van Dalen, ... The Lancet Oncology 17 (8), 1158-1170, 2016	486	2016
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients MJB Taphoorn, L Claassens, NK Aaronson, C Coens, M Mauer, D Osoba, ... European Journal of Cancer 46 (6), 1033-1040, 2010	415*	2010
Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study F Amant, G von Minckwitz, SN Han, M Bontenbal, AE Ring, J Giermek, ... Journal of clinical oncology 31 (20), 2532-2539, 2013	407	2013
Treatment of breast cancer during pregnancy: an observational study S Loibl, SN Han, G von Minckwitz, M Bontenbal, A Ring, J Giermek, ... The lancet oncology 13 (9), 887-896, 2012	394	2012
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer … R Gray, R Bradley, J Braybrooke, Z Liu, R Peto, L Davies, D Dodwell, ... The lancet 393 (10179), 1440-1452, 2019	376	2019
Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised … MS van Ramshorst, A van der Voort, ED van Werkhoven, IA Mandjes, ... The Lancet Oncology 19 (12), 1630-1640, 2018	362	2018
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer M Knauer, S Mook, EJT Rutgers, RA Bender, M Hauptmann, ... Breast cancer research and treatment 120, 655-661, 2010	355	2010
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER) JM Bueno-de-Mesquita, WH van Harten, VP Retel, LJ van't Veer, ... The lancet oncology 8 (12), 1079-1087, 2007	342	2007
Late effects of high‐dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging MB de Ruiter, L Reneman, W Boogerd, DJ Veltman, M Caan, G Douaud, ... Human brain mapping 33 (12), 2971-2983, 2012	313	2012
Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and … CM Schilder, C Seynaeve, LV Beex, W Boogerd, SC Linn, CM Gundy, ... Journal of Clinical Oncology 28 (8), 1294-1300, 2010	310	2010
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study CA Drukker, JM Bueno‐de‐Mesquita, VP Retèl, WH van Harten, ... International journal of cancer 133 (4), 929-936, 2013	301	2013
Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene R Meuwissen, SC Linn, M van der Valk, WJ Mooi, A Berns Oncogene 20 (45), 6551-6558, 2001	270	2001
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer AH Honkoop, PJ Van Diest, JS De Jong, SC Linn, G Giaccone, ... British journal of cancer 77 (4), 621-626, 1998	267	1998
Understanding the biology of triple-negative breast cancer C Criscitiello, HA Azim Jr, PC Schouten, SC Linn, C Sotiriou Annals of oncology 23, vi13-vi18, 2012	226	2012
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients MA Vollebergh, EH Lips, PM Nederlof, LFA Wessels, MK Schmidt, ... Annals of oncology 22 (7), 1561-1570, 2011	222	2011
Validation of 70-gene prognosis signature in node-negative breast cancer JM Bueno-de-Mesquita, SC Linn, R Keijzer, J Wesseling, DSA Nuyten, ... Breast cancer research and treatment 117, 483-495, 2009	221	2009

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores